Effect Of Virtual Reality Distraction on Symptom Control and Anxiety in Children With Leukemia

Study Overview
=================
Brief Summary
-----------------
This study aim to evaluate the effect of virtual reality distraction on symptom management and anxiety in children aged 7-18 years with leukemia.

Detailed Description
-----------------
While the virtual reality initiative was applied to the children in the study group, no harm was given to the children in the control group. The virtual reality distraction method will not be applied to the control group. After the child and his family are informed about the study, their written informed consent will be obtained. When the patients were admitted to the clinic the day before chemotherapy treatment was started, the symptom screening scale and anxiety scale will be applied. Control Group: The researcher stated that no additional procedure will be applied to the children in the control group and that the symptom screening scale and anxiety measurement will be obtained by explaining that he/she should evaluate the scale every day for 3 days. VR group; A distraction intervention will be applied for 10-15 minutes once a day with VR glasses. The symptom screening scale and anxiety measurement will be obtained by explaining that he/she should evaluate the scale every day for 3 days.

Official Title
-----------------
Effect Of Virtual Reality Distraction on Symptom Control and Anxiety in Children With Leukemia: A Randomized Controlled Trial

Conditions
-----------------
Symptom Cluster, Anxiety

Intervention / Treatment
-----------------
* Device: virtual reality


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Pediatric patients aged 7-18 years receiving leukemia treatment in the Pediatric Hematology Service 4 weeks after diagnosis (not in the induction phase) No need for blood product transfusion (less than 8 mg/dl for hematological malignancies, less than 7 mg/dl for oncological malignancies) Consent to voluntarily participate in the study and written consent from the child and parent Exclusion Criteria: The child has a physical and psychological deficit that will prevent him from wearing glasses to watch virtual reality Having a symptom of nausea and vomiting Being in a terminal period Undergoing a surgical operation Unwillingness to participate in the study Having a history of vertigo (having a history of train, motion sickness) The child and family do not know Turkish

Ages Eligible for Study
-----------------
Minimum Age: 7 Years
Maximum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Supportive Care
Allocation: Randomized
Intervention Model: Parallel Assignment
Interventional Model Description: Randomised
Masking: Single


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: virtual reality distraction<br>watching the application by wearing virtual glasses to the child during the 1st, 2nd and 3rd days of chemotherapy treatment | Device: virtual reality<br>* virtual reality distraction<br>|
| No Intervention: control<br>no virtual reality distraction | |

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Change in symptom cluster | Symptom by Symptom Screening Tool(8-18) in SSPedi-Pediatric Patients with Cancer | during the 1st, 2nd and 3rd days of chemotherapy treatment | 
| Change in anxiety | anxiety by State-Trait Anxiety Inventory for Children | (during the 1st, 2nd and 3rd days of chemotherapy treatment) |